Enzymatica Publ Ab Stock Current Valuation

ENZY Stock  SEK 3.25  0.05  1.56%   
Valuation analysis of Enzymatica Publ AB helps investors to measure Enzymatica Publ's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
3.25
Please note that Enzymatica Publ's price fluctuation is unstable at this time. Calculation of the real value of Enzymatica Publ AB is based on 3 months time horizon. Increasing Enzymatica Publ's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Enzymatica Publ AB is useful when determining the fair value of the Enzymatica stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Enzymatica Publ. Since Enzymatica Publ is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Enzymatica Stock. However, Enzymatica Publ's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  3.25 Real  3.13 Hype  3.25
The real value of Enzymatica Stock, also known as its intrinsic value, is the underlying worth of Enzymatica Publ AB Company, which is reflected in its stock price. It is based on Enzymatica Publ's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Enzymatica Publ's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Enzymatica Publ's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
3.13
Real Value
6.47
Upside
Estimating the potential upside or downside of Enzymatica Publ AB helps investors to forecast how Enzymatica stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Enzymatica Publ more accurately as focusing exclusively on Enzymatica Publ's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.163.256.59
Details

Enzymatica Current Valuation Analysis

Enzymatica Publ's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Enzymatica Publ Current Valuation

    
  613.36 M  
Most of Enzymatica Publ's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enzymatica Publ AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Enzymatica Publ AB has a Current Valuation of 613.36 M. This is 95.73% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all Sweden stocks is 96.31% higher than that of the company.

Enzymatica Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Enzymatica Publ's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Enzymatica Publ could also be used in its relative valuation, which is a method of valuing Enzymatica Publ by comparing valuation metrics of similar companies.
Enzymatica Publ is currently under evaluation in current valuation category among related companies.

Enzymatica Fundamentals

About Enzymatica Publ Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Enzymatica Publ AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enzymatica Publ using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enzymatica Publ AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally. Enzymatica AB was incorporated in 2007 and is based in Lund, Sweden. Enzymatica operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 24 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Enzymatica Publ in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Enzymatica Publ's short interest history, or implied volatility extrapolated from Enzymatica Publ options trading.

Pair Trading with Enzymatica Publ

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enzymatica Publ position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzymatica Publ will appreciate offsetting losses from the drop in the long position's value.

Moving together with Enzymatica Stock

  0.74ERIC-A TelefonaktiebolagetPairCorr

Moving against Enzymatica Stock

  0.64VOLV-A AB VolvoPairCorr
  0.64VOLCAR-B Volvo Car ABPairCorr
  0.63VOLV-B AB VolvoPairCorr
  0.63ATCO-B Atlas Copco ABPairCorr
The ability to find closely correlated positions to Enzymatica Publ could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enzymatica Publ when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enzymatica Publ - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enzymatica Publ AB to buy it.
The correlation of Enzymatica Publ is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enzymatica Publ moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enzymatica Publ AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enzymatica Publ can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Enzymatica Publ Piotroski F Score and Enzymatica Publ Altman Z Score analysis.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Enzymatica Stock analysis

When running Enzymatica Publ's price analysis, check to measure Enzymatica Publ's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzymatica Publ is operating at the current time. Most of Enzymatica Publ's value examination focuses on studying past and present price action to predict the probability of Enzymatica Publ's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzymatica Publ's price. Additionally, you may evaluate how the addition of Enzymatica Publ to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Please note, there is a significant difference between Enzymatica Publ's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enzymatica Publ is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enzymatica Publ's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.